Procurement Summary
Country: Kazakhstan
Summary: Acquisition of Chemical Reagents, Amt: 4025000.00
Deadline: 03 Sep 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 125314404
Document Ref. No.: 15296180-1
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: KZT 4025000.00
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Lots: "DNA of polymerase with a hot start for molecular work, 1000 units. Concentration of 5000 units per ml. Composition: a mixture of TAQ DNA polymerase and pharmacid inhibitor Mechanism of action: APTAMAMAMA reversibly inhibits the enzyme at a temperature below 45 C upon transition to thermocyting inhibitor conditions Inactivated by releasing the active enzyme does not require the preliminary stage of activation at high temperatures convenience: allows you to collect PCR reaction at room temperature without the risk of non-specific amplification enzymatic activity: 5 '→ 3' DNA-polymerase activity, 5 'Flop-endonucleic activity Activity of the buffer: supplies with a 10x standard TAQ buffer, the buffer does not contain detergents, compatible with most existing PCR systems use: standard PCR, highly specific amplification, complex or low-concentrated matrices, genotyping, diagnosis, clonal PCR | Transcriptase, 50, 000 units. Concentration of 200, 000 units per ml. Type of enzyme: RNA-dependent DNA polymerase Function: synthesizes the complementary DNA (KDNK) chain, starting with a primer, uses RNA as a matrix (for the synthesis of KDNK) or a single-stranded DNA enzymatic features: does not have 3 ' → 5 'exonucleic activity (there is no error adjustment function) application: synthesis of the first KDNK circuit for PCR or Qpcr, genes expression studies, creating a KDNK-bibliotek, RT-PCR and RT-QPCr Source: Molney Murine Leukemia Likemia Virus. Virus)
Documents
Tender Notice